Natus Medical Incorporated NTUS
$ 31.08
1.94%
Quarterly report 2022-Q1
added 12-23-2023
Natus Medical Incorporated Financial Statements 2011-2024 | NTUS
Annual Financial Statements Natus Medical Incorporated
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
799 M | 673 M | 1.11 B | 1.13 B | 1.24 B | 1.24 B | 1.14 B | 1.18 B | 788 M | 349 M | 323 M |
Shares |
33.7 M | 33.6 M | 33.7 M | 33.1 M | 32.6 M | 32.5 M | 32.3 M | 31.5 M | 30 M | 29 M | 28.6 M |
Historical Prices |
23.7 | 20 | 33 | 34 | 38.2 | 34.8 | 48 | 36 | 22.5 | 11.2 | 9.43 |
Net Income |
13.2 M | -16.6 M | -15.7 M | -22.9 M | -20.3 M | 42.6 M | 37.9 M | 32.5 M | 22.9 M | 3.88 M | -11.7 M |
Revenue |
473 M | 416 M | 495 M | 531 M | 501 M | 382 M | 376 M | 356 M | 344 M | 292 M | 233 M |
Cost of Revenue |
- | - | 197 M | 218 M | 213 M | 145 M | 145 M | 138 M | 139 M | 129 M | 102 M |
Gross Profit |
274 M | 217 M | 292 M | 304 M | 281 M | 235 M | 228 M | 214 M | 202 M | 163 M | 131 M |
Operating Income |
23.8 M | -20.2 M | -15.7 M | -24.6 M | 8.72 M | 55.3 M | 53.5 M | 45.9 M | 34.7 M | 5.11 M | -10.3 M |
Interest Expense |
1.87 M | 3.66 M | 4.94 M | 6.79 M | 5.08 M | 430 K | 352 K | 438 K | 1.68 M | 489 K | 268 K |
EBITDA |
51.9 M | 7.92 M | 15.1 M | 9.3 M | 38.8 M | 65.8 M | 63.1 M | 57.6 M | 47.1 M | 17.9 M | 19.5 M |
Operating Expenses |
250 M | 233 M | 263 M | 291 M | 272 M | 178 M | 172 M | 169 M | 168 M | 158 M | 121 M |
General and Administrative Expenses |
52.8 M | 49.1 M | 59.6 M | 68.7 M | 74.4 M | 50.9 M | 46.4 M | 49.3 M | 48.5 M | 51 M | 32.9 M |
All numbers in USD currency
Quarterly Income Statement Natus Medical Incorporated
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | - | 34.1 M | 34.2 M | 33.6 M | 33.6 M | 33.6 M | 33.9 M | 33.8 M | 33.8 M | 33.8 M | 34.1 M | 33.7 M | 33.6 M | 33.6 M | 33.8 M | 33.3 M | 32.9 M | 32.8 M | 33.1 M | 32.6 M | 32.5 M | 32.5 M | 32.9 M | 32.4 M | 32.4 M | 32.6 M | 33.2 M | 32.4 M | 32.3 M | 32.1 M | 32.6 M | 31.6 M | 31.4 M | 31.1 M | 31.4 M | 30.1 M | 29.7 M | 29.6 M | 30.1 M | 29.1 M | 28.9 K | 28.9 K | 29.4 M | 28.6 K | 28.4 K | 28.3 M |
Net Income |
- | - | - | 1.9 M | - | 5.57 M | 3.46 M | 2.4 M | - | -9.32 M | -8.9 M | -3.6 M | - | 8.23 M | 3.49 M | -30.4 M | - | -5.58 M | -2.58 M | -3.15 M | - | -8.51 M | -5.03 M | 348 K | - | 13.3 M | 10.5 M | 8.54 M | - | 10.9 M | 9.85 M | 8.6 M | - | 7.82 M | 7.46 M | 6.76 M | - | 6.29 M | 4.02 M | 3.44 M | - | -1.75 M | 324 K | 289 K | - | 154 K | 2.36 M | 3.1 M |
Revenue |
- | - | - | 120 M | - | 114 M | 116 M | 115 M | - | 103 M | 84.8 M | 109 M | - | 123 M | 126 M | 115 M | - | 131 M | 131 M | 129 M | - | 123 M | 123 M | 125 M | - | 90.9 M | 96 M | 87.3 M | - | 94.6 M | 91.9 M | 89.4 M | - | 89.9 M | 86.3 M | 85.6 M | - | 85.4 M | 82.2 M | 85.8 M | - | 81 M | 61 M | 59.4 M | - | 51.3 M | 58.1 M | 59.1 M |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | 48.7 M | 52.2 M | 46.4 M | - | 51.6 M | 52.9 M | 55.4 M | - | 47.1 M | 54.6 M | 56.9 M | - | 32.2 M | 37.9 M | 32.5 M | - | 35.5 M | 33.8 M | 35.1 M | - | 33.2 M | 35.5 M | 34 M | - | 34.1 M | 33.9 M | 36.6 M | - | 36.5 M | 26.7 M | 26.1 M | - | 23.8 M | 25 M | 24.4 M |
Gross Profit |
- | - | - | 65.4 M | - | 67.7 M | 66.4 M | 66.5 M | - | 47.5 M | 40.6 M | 62.8 M | - | 73.3 M | 71.4 M | 66.5 M | - | 77.1 M | 75 M | 71.7 M | - | 74.2 M | 66.1 M | 66.7 M | - | 58.1 M | 57.5 M | 54.3 M | - | 58.4 M | 57.4 M | 53.6 M | - | 55.6 M | 50.7 M | 50.6 M | - | 51.3 M | 48.4 M | 49.2 M | - | 44.6 M | 34.3 M | 33.3 M | - | 27.6 M | 33.1 M | 34.7 M |
Operating Income |
- | - | - | 4.18 M | - | 8.54 M | 6.01 M | 4.52 M | - | -9.94 M | -12 M | -3.23 M | - | 7.85 M | 6.63 M | -38.1 M | - | -2.91 M | -3.79 M | -2.73 M | - | 8.54 M | -6.28 M | 1.4 M | - | 15.2 M | 13.9 M | 11.2 M | - | 16.1 M | 14 M | 13.3 M | - | 12.9 M | 9.94 M | 9.39 M | - | 9.14 M | 6.16 M | 4.86 M | - | -4.57 M | 617 K | 428 K | - | -1.04 M | 3.16 M | 5.04 M |
Interest Expense |
- | - | - | 267 K | - | 332 K | 556 K | 766 K | - | 1.11 M | 976 K | 717 K | - | 1.17 M | 1.47 M | 1.53 M | - | 1.65 M | 1.64 M | 1.96 M | - | 1.04 M | 1.28 M | 980 K | - | 223 K | 97 K | 31 K | - | - | - | 1 K | - | 104 K | 184 K | 264 K | - | 138 K | 469 K | 477 K | - | 215 K | 8 K | 8 K | - | 47 K | 64 K | - |
EBITDA |
- | - | - | 10.9 M | - | 10 M | 7.51 M | 11.8 M | - | 11.1 M | 1.64 M | 3.76 M | - | 30.8 M | 22.1 M | -30.4 M | - | 22.7 M | 12.9 M | 5.19 M | - | 29.4 M | 7.54 M | 8.15 M | - | 28.1 M | 22.3 M | 15.4 M | - | 27.4 M | 21.2 M | 16.3 M | - | 21.4 M | 15.6 M | 12.7 M | - | 18.7 M | 12.5 M | 7.99 M | - | -3.57 M | 1.92 M | 3.27 M | - | 1.36 M | 4.1 M | 7.59 M |
Operating Expenses |
- | - | - | 61.2 M | - | 59.2 M | 60.4 M | 62 M | - | 57.5 M | 52.6 M | 66 M | - | 65.5 M | 64.8 M | 105 M | - | 80 M | 78.8 M | 74.4 M | - | 65.7 M | 72.4 M | 65.3 M | - | 42.9 M | 43.5 M | 43 M | - | 42.3 M | 43.4 M | 40.3 M | - | 42.8 M | 40.7 M | 41.2 M | - | 42.2 M | 42.2 M | 44.4 M | - | 49.1 M | 33.7 M | 32.9 M | - | 28.6 M | 29.9 M | 29.7 M |
General and Administrative Expenses |
- | - | - | 12.8 M | - | 12.9 M | 12.6 M | 14.9 M | - | 12.4 M | 11.2 M | 13.2 M | - | 15.4 M | 12.7 M | 16.3 M | - | 15.8 M | 23.7 M | 17.4 M | - | 17.3 M | 24.2 M | 16 M | - | 12.8 M | 11.9 M | 12.5 M | - | 10 M | 11.7 M | 11.6 M | - | 12.7 M | 10.2 M | 11.7 M | - | 14.3 M | 11.8 M | 14 M | - | 18.8 M | 10.9 M | 9.5 M | - | 7.81 M | 7.99 M | 9.03 M |
All numbers in USD currency